New Zealand markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
80.32+0.37 (+0.46%)
At close: 04:00PM EST
80.35 +0.03 (+0.04%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 30.62B
Enterprise value 24.50B
Trailing P/E 7.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.43
Price/book (mrq)2.28
Enterprise value/revenue 2.70
Enterprise value/EBITDA -13.49

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 3-51.58%
S&P500 52-week change 314.91%
52-week high 3217.25
52-week low 362.55
50-day moving average 383.37
200-day moving average 3115.99

Share statistics

Avg vol (3-month) 34.13M
Avg vol (10-day) 33.04M
Shares outstanding 5381.28M
Implied shares outstanding 6381.28M
Float 8344.15M
% held by insiders 19.63%
% held by institutions 169.20%
Shares short (14 Nov 2023) 422.38M
Short ratio (14 Nov 2023) 44.09
Short % of float (14 Nov 2023) 47.81%
Short % of shares outstanding (14 Nov 2023) 45.87%
Shares short (prior month 12 Oct 2023) 418.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -38.00%
Operating margin (ttm)-109.89%

Management effectiveness

Return on assets (ttm)-7.32%
Return on equity (ttm)-22.04%

Income statement

Revenue (ttm)9.12B
Revenue per share (ttm)23.78
Quarterly revenue growth (yoy)-45.60%
Gross profit (ttm)10.55B
Net income avi to common (ttm)-3.47B
Diluted EPS (ttm)-9.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.57B
Total cash per share (mrq)19.86
Total debt (mrq)1.46B
Total debt/equity (mrq)10.81%
Current ratio (mrq)2.46
Book value per share (mrq)35.31

Cash flow statement

Operating cash flow (ttm)-2.08B
Levered free cash flow (ttm)-1.11B